Status:

COMPLETED

An Upstream Palliative Care Intervention for Rural and African-American Advanced Cancer Family Caregivers

Lead Sponsor:

University of Alabama at Birmingham

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Cancer, Metastatic

Family Members

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The burden placed on advanced cancer family caregivers (FCGs) and the toll on their mental and physical health have never been greater and is particularly pernicious for underserved groups in the Sout...

Detailed Description

Enrollment goal was increased from 60 to 70 participants due to attrition.

Eligibility Criteria

Inclusion

  • FAMILY CAREGIVERS
  • ≥18 years of age;
  • Self-endorsing or identified by the patient as "a relative, friend, or partner that has a close relationship with you and who assists you with your medical care and who may or may not live in the same residence as you and who is not paid for their help";
  • Either caring for a patient: a) residing in a rural zip code (as classified by the U.S. Census' Rural-Urban Commuting Area \[RUCA\] system as small rural, large rural, and isolated \[hereafter referred to as "rural"\]) or b) who is African-American/Black;
  • Caring for a patient with advanced-stage cancer (see definition under Patient Inclusion criteria below); and
  • Caregivers will need NOT need to have an agreeable patient willing to participate in the study (for data collection only).
  • English-speaking and able to complete baseline measures.

Exclusion

  • 1\) Self-reported severe mental illness (i.e., schizophrenia, bipolar disorder, or major depressive disorder), dementia, active suicidal ideation, uncorrected hearing loss, or active substance abuse
  • PATIENTS
  • Inclusion Criteria:
  • ≥18 years of age;
  • Diagnosed within past 60 days of initial screening with an advanced cancer, defined as metastatic stage III/IV solid-tumor cancers of the lung, breast, gynecologic, head and neck, gastrointestinal, genitourinary cancer, and melanoma; and
  • Either: a) resides in a rural zip code or b) is African-American/Black.

Key Trial Info

Start Date :

October 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2021

Estimated Enrollment :

105 Patients enrolled

Trial Details

Trial ID

NCT03464188

Start Date

October 20 2018

End Date

March 30 2021

Last Update

May 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35226